Semaglutide Patent Expiry Creates Rs 50,000 Cr Opportunity
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
Tesla's global EV crown slips to China's BYD after a 9% delivery drop in 2025. Intense competition and expiring US tax credits hit sales. Can Musk's robotaxi and robotics pivot revive fortunes? Read the full analysis.
Chinese automaker BYD achieves its 2025 sales target, delivering 4.6 million vehicles and likely surpassing Tesla. Discover the challenges and global ambitions shaping the EV industry's new leader.
Vietnamese EV giant VinFast has made a stunning entry into India, securing land in Tamil Nadu for a massive $500 million plant and planning a nationwide retail network. Discover their ambitious strategy to challenge Tesla and Tata.
New research reveals bariatric surgery delivers five times more weight loss than GLP-1 drugs like Ozempic over two years. Discover the real-world data and what it means for obesity treatment.
SoftBank Group finalises a massive $4.1 billion investment in OpenAI, acquiring an 11% stake. This strategic move intensifies the global AI race. Read more for details and analysis.
Explore how 2025's weight-loss drug boom in India shifted focus from fitness to thinness, raising concerns about medicalisation, side effects, and societal pressure. Read the full analysis.
A Belagavi engineer, financed by Rajasthan businessmen, set up drug labs in Bengaluru for easy money. CCB busts the operation. Read the shocking details.
A Belagavi native engineer, financed by Rajasthan businessmen, set up drug-processing units in Bengaluru for easy money, reveals CCB. Read the shocking details.
Karnataka Industries Department clarifies the 53.56-acre land sold by Infosys to Puravankara was private, not government-allotted. Details on the Rs 250-crore deal and the ensuing social media debate.
As GLP-1 drugs like Ozempic launched in India, experts warn they are not a magic fix. Sustainable metabolic health requires diet, exercise, and stress management. Learn why.
Explore the social and economic impact of GLP-1 drugs like Ozempic & Mounjaro in India. A ₹1,000 crore market is poised for massive growth. Share your thoughts.
New research reveals GLP-1 weight-loss drugs like Ozempic significantly cut grocery and restaurant spending. Discover the impact on food habits in India and globally.
Nvidia seals its largest-ever $20 billion all-cash acquisition, buying AI chip startup Groq's assets. Deal excludes Groq Cloud. Get the full story here.
Women share harrowing experiences of stopping anti-obesity drugs like Wegovy. Experts warn 60-80% weight returns without a plan. Learn about the side effects and new drugs in India.
Rapid weight loss from GLP-1 drugs like Ozempic is causing 'Ozempic face'—facial thinning & sagging. Learn about prevention, treatments, and the 50% rise in cosmetic procedures. #Beauty #Skincare
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Coffee is now a daily ritual. Our guide helps you choose the right coffee machine for home or office, balancing taste, convenience, and maintenance. Find your perfect brew today!
Discover the real reason your coffee tastes off—it's not the beans. Learn the simple monthly cleaning routine to restore perfect flavour and faster brewing.
Actor Ram Kapoor opens up about his 55kg weight loss journey, battling type-2 diabetes, and his mindset shift. Discover his inspiring health transformation story.
Psyllium husk, dubbed 'Desi Ozempic,' is trending as a natural appetite suppressant. Discover how this common fiber compares to prescription drugs and its role in weight management.
Amazon is reportedly in fluid discussions to invest $10 billion or more in ChatGPT-maker OpenAI. The deal could reshape the AI landscape. Read the latest details.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
Netflix, the world's largest streaming service, is set to purchase Warner Bros Discovery's studios and streaming assets for a staggering $72 billion. This deal could reshape the global entertainment landscape. Read more about the implications.
Sheetal Tejwani, a key accused in the Pune land deal case linked to Deputy CM Ajit Pawar's son, sent to police custody till December 11. Read the full details of the alleged irregularities.
WHO releases first-ever global guidelines for GLP-1 medicines to treat obesity, a chronic disease. Learn about the key recommendations and new mental health warnings from Australia.
Australia's TGA issues a safety warning for GLP-1 drugs like Ozempic, linking them to suicidal thoughts and depression. Over 500,000 users affected. Learn the risks and what patients must do.
The 'Ozempets' trend of using human weight-loss drugs like Ozempic on pets is growing. Experts warn of severe risks as these drugs are not approved for animals. Learn safe alternatives.
India plans to discuss buying Russian Su-57 jets & S-500 missile shield during Putin's visit, balancing its historic defense ties with Moscow against US pressure. Details inside.